Cantelli I, Lombardi G, Bracchetti D
G Ital Cardiol. 1979;9(12):1413-23.
The effect of verapamil on ST changes was evaluated in 10 selected patients with acute myocardial infarction admitted to the Coronary Care Unit within 8 hours after the onset of symptoms. To evaluate the extent of ischemia it has been used the magnitude and direction of the ST vector derived from X, Y and Z leads of the Frank vector system. After a control period of 2 hours, during which the changes of the ST vector magnitude were assessed, each patient received 0.1 mg/Kg verapamil intravenously, ST vector magnitude (STVM), ST azimuth (STAZ), ST elevation (STEL), heart rate, systemic blood pressure and pressure-rate product were assessed 5, 15, 30, 45, 60, 75, 90, 105 and 120 minutes after the administration of the drug. Verapamil produced a significant progressive decrease in STVM (from a mean of 254 +/- 44 muV at the end of the control period, to 139 +/- 25 muV after 2 hours; P < 0.01). Systolic blood pressure decreased significantly throughout the trial; the most significant decrease was registered immediately after the infusion of verapamil (from a mean of 134 +/- 3 mmHg to 121 +/- 3 mmHg; P < 0.001). Pressure-rate product declined slightly. No significant change in STVM was observed in 10 control patients with acute myocardial infarction examined over a 4 hours period. The apparent protective effect of verapamil in myocardial ischemia is discussed in relation to its calcium-antagonistic properties in excitable tissues.
在10例症状发作后8小时内入住冠心病监护病房的急性心肌梗死患者中,评估了维拉帕米对ST段改变的影响。为评估缺血程度,采用了从Frank向量系统的X、Y和Z导联得出的ST向量的大小和方向。在2小时的对照期内评估ST向量大小的变化,之后,每位患者静脉注射0.1mg/kg维拉帕米,在给药后5、15、30、45、60、75、90、105和120分钟评估ST向量大小(STVM)、ST方位(STAZ)、ST抬高(STEL)、心率、体循环血压和压力-心率乘积。维拉帕米使STVM显著逐渐降低(从对照期末的平均254±44μV降至2小时后的139±25μV;P<0.01)。在整个试验过程中收缩压显著降低;在输注维拉帕米后立即出现最显著的降低(从平均134±3mmHg降至121±3mmHg;P<0.001)。压力-心率乘积略有下降。在4小时内检查的10例急性心肌梗死对照患者中,未观察到STVM有显著变化。结合维拉帕米在可兴奋组织中的钙拮抗特性,讨论了其对心肌缺血的明显保护作用。